This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Agents triggering airway hyperactivity

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In response to a number of stimuli and in the apparent absence of an allergic IgE mediated response, individuals with asthma may experience bronchoconstriction and airflow limitation in response to stimuli such as:

  • upper respiratory tract infection
    • predominantly viral
    • more common in children than in adults and during winter than in summer
  • smoking
  • occupational sensitisers - for example
    • colophony fumes in the soldering and the electronics industry
    • chemicals - isocyanates in industrial coatings, platinum salts, aluminium (1)
  • psychological factors such as stress and emotion
  • exercise
  • cold air and exercise
  • drugs - such as beta blockers, aspirin and NSAIDs, angiotensin-converting enzyme inhibitors (ACEI’s) (1)
    • ACEIs - symptoms of airway obstruction in relation to treatment with angiotensin converting enzyme inhibitors seem to be a rare but potentially serious reaction generally occurring within the first few weeks of treatment (2)

Variation in symptoms throughout the working week may provide a clue to an occupational allergen. A seasonal pattern implies seasonal allergen exposure.


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.